Biotech · Private company
MEI Pharma, Inc.
Track this companyFree. Adds MEI Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- BendamustinePhase 3 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- CHOPPhase 3 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 3 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- ZandelisibPhase 3 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 2 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 2 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- ZandelisibPhase 2 · CLLClinicalTrials.gov · fetched Nov 12, 2026
- Zandelisib (ME-401)Phase 2 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- ME-344Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- ME-401Phase 1 · Chronic Lymphocytic Leukemia (CLL)ClinicalTrials.gov · fetched Nov 12, 2026
- RituximabPhase 1 · Chronic Lymphocytic Leukemia (CLL)ClinicalTrials.gov · fetched Nov 12, 2026
- voruciclib and venetoclaxPhase 1 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- voruciclib monotherapyPhase 1 · Follicular Lymphoma (FL)ClinicalTrials.gov · fetched Nov 12, 2026
- ZanubrutinibPhase 1 · Chronic Lymphocytic Leukemia (CLL)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal CancerPHASE1 · TERMINATED · started Aug 7, 2023ClinicalTrials.gov NCT05824559 · fetched Nov 12, 2026
- Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLLPHASE2 · WITHDRAWN · started Nov 22, 2022ClinicalTrials.gov NCT05209308 · fetched Nov 12, 2026
- Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)PHASE3 · TERMINATED · started Aug 13, 2021ClinicalTrials.gov NCT04745832 · fetched Nov 12, 2026
- Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)PHASE2 · TERMINATED · started Jun 25, 2019ClinicalTrials.gov NCT03768505 · fetched Nov 12, 2026
- A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLPHASE1 · TERMINATED · started May 31, 2018ClinicalTrials.gov NCT03547115 · fetched Nov 12, 2026
- A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's LymphomaPHASE1 · TERMINATED · started Oct 1, 2016ClinicalTrials.gov NCT02914938 · fetched Nov 12, 2026